Bioscience – Groundbreaking Research & Diagnostics: Stockholm (2025)

Anna Törner: ”If I fall seriously ill, I’ll move to Finland”

”It is both undignified and undemocratic that cancer patients must travel to Finland to uphold a façade of fairness that does not truly exist”, Anna Törner writes in a column.

Lifs Sofia Wallström tar plats i EFPIA:s styrelse

Lifs vd Sofia Wallström har valts in i styrelsen för den europeiska branschorganisationen EFPIA.

Jeeves välkomnar Two till sin partnerkanal

Vi på Jeeves fortsätter utöka vår partnerkanal och är glada att kunna meddela att vi nu välkomnar partner nummer två – det vill säga Two – in i familjen. Two är...

Sneak Peek of ZEISS Metrology Expert Tips Season 2

The second season of the video series starts in January 2026, but you can discover more about the highlights of Season 2 now.

A billion-dollar acquisition makes Novo Nordisk even bigger in obesity

Danish pharmaceutical giant Novo Nordisk acquires Montreal-based Inversago Pharma, which develops treatments for obesity and diabetes.

Svenske Martin Kulldorff bland nya vaccinrådgivare – utnämnd av Kennedy

USA:s hälsominister Robert Kennedy Jr. utsåg på onsdagen åtta nya ledamöter till CDC:s rådgivande vaccinkommitté (ACIP), efter att plötsligt ha avskedat hela de...

Storbritannien vill korta starttiden för kliniska studier med 100 dagar

Krävande byråkrati sätter käppar ihjulet för medicinsk forskning i Storbritannien. Nu vill regeringen kraftigt korta tiden för att starta kliniska studier.

Large study: The benefits and risks of obesity medications

Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

Nocebo – the evil twin that makes you feel worse

The placebo effect is well known in healthcare, but not so its opposite: nocebo. “The effect is small, but it can have major repercussions,” says Uppsala resear...

Novartis miljardsatsar inom Parkinsons

Novartis betalar upp till 2 miljarder dollar, motsvarande nästan 19 miljarder kronor, för rättigheterna till ett läkemedelsprojekt inom Parkinsons sjukdom.

Chiesi satsar på leverinriktad genterapi

Läkemedelsbolaget Chiesi tar ytterligare kliv in på genterapiområdet genom ett licensavtal med amerikanska Arbor Biotechnologies.

Accurate removal of prostate tissue

Medical robots play an important role in diagnostics

Microscope or Measuring Machine? Both!

Watch our demo recording with features, software and best-practices.

In search of Marcel Proust's lost health

A great writer, but also a weak person and a hypochondriac. That has been the usual image of Marcel Proust. But the pediatrician and literary scholar Carl Lindg...

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

Beta-blockers are often given unnecessarily, a study finds – “This will affect future practice”

Patients who have suffered a minor heart attack do not benefit from beta-blockers, according to a major new study that may change guidelines for cardiac care.

Improved processes and more

Discover the full potential and benefits.

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Copenhagen (2026)

SupraCube - In life Science

restricted. We now present the SupraCube, the first concept in which the superconductor unit can be separated from the electrical cooler and can operate autonomously for up to two...

“Conducting research at universities is becoming more and more like working at a research hotel”

The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at...

“A major energy boost for the entire cancer vaccine field”

The development of cancer vaccines has accelerated in recent years. Norwegian Ultimovacs is one of the companies attempting to develop a new type of treatment l...

Ytterligare läkemedelskandidat mot Alzheimers droppas

Ett litet schweiziskt biotechbolag avbryter en fas II-studien med sin läkemedelskandidat mot Alzheimers sjukdom. Beskedet kommer inte långt efter att Biogen och...